Perkins Coie Trust »

Crispr Therapeutics shares owned by Perkins Coie Trust

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Perkins Coie Trust from 13F filings

Historical chart of Perkins Coie Trust investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Perkins Coie Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Perkins Coie Trust

Quarter filed Position value Share count Share price at filing
2024-09-30 $9.4k 200 46.97
2024-06-30 $11k 200 54.00
2024-03-31 $14k 200 68.15
2023-12-31 $13k 200 62.60